N/A N=93 Health Services Research

Development and Implementation of Electronic Decision Aids for Genetic Testing in Inherited Cancer Syndromes

Genetic Testing

Bottom Line

View on ClinicalTrials.gov: NCT04704193 ↗

Enrolled (actual)

Serious AEs

0.0%

Results posted

Aug 2024

Primary outcome: Primary: Participant Satisfaction With How Educational Information is Presented in the Decision Aid — 1; 3; 29; 55 Participants

Study Design & Population

Study type: Interventional
Phase: N/A
Interventions: Survey of Decision Aid (Other)
Age: Adult, Older Adult · 18+ yrs
Sex: All
Sponsor: Massachusetts General Hospital
Primary completion: Dec 2023

Outcome Measures

Outcome	Result	p-value
PRIMARY Participant Satisfaction With How Educational Information is Presented in the Decision Aid	1; 3; 29; 55; 2; 4	—
SECONDARY Total Time Spent on Decision Aid	13.7	—

Summary

An electronic decision aid will be used to assist individuals in choosing a multi-gene panel with their medical oncologist instead of a genetic counselor. A decision aid may facilitate quality decisions around the selection of a specific multi-gene panel without a genetic counselor. Upon completion of the decision aid, participants will be asked to indicate their decision about whether to pursue genetic testing and which specific multi-gene panel to pursue. A survey will then be administered to assess participants' opinions on the decision aid.

Eligibility Criteria

Inclusion Criteria

Adults (18 years of age or older)
Diagnosed with malignant ovarian tumor or malignant pancreatic adenocarcinoma

Exclusion Criteria

Children (<18 years of age)
Unable to complete surveys
Previous germline genetic testing

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT04704193). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.